Cbdmd, INC Form 4 insider transactions

Director Jeffrey H. Porter was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.

Director Kevin Roe was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.

Director Sybil Nichole Swift was granted 1,572 restricted stock units as compensation for board services.

Director Bakari Sellers was granted 1,572 restricted stock units as compensation for board service at cbdMD, Inc.

Director Scott Stephen was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.

Director William F. Raines III was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.

cbdMD Director and 10% Owner Clark R. Crosnoe reported the sale of 550,701 shares of common stock across multiple transactions on December 17, 2025.

cbdMD's CEO and CFO, Thomas Ronan Kennedy, acquired 445,000 shares of restricted common stock under the company's 2025 Equity Compensation Plan.

Director Jeffrey H. Porter acquired 1,572 restricted stock units of cbdMD, Inc. on May 16, 2025, as compensation for board service.

Director William F. Raines III reports acquiring 1,572 shares of cbdMD, Inc. common stock and disposing of 12,104 shares on May 16, 2025, according to a Form 4 filing.

Director Kevin Roe reports acquiring 1,572 shares of cbdMD, Inc. common stock and disposing of 0 shares on May 16, 2025, according to a Form 4 filing.

Director Bakari Sellers reports acquisition and disposal of cbdMD, Inc. stock and restricted stock units.

Director Stephen Scott G. reports acquiring 1,572 shares of common stock and disposing of 2,840 shares.

Director Sybil Swift reports acquiring and disposing of cbdMD, Inc. common stock and restricted stock units.

Director Jeffrey Porter reports the automatic conversion of 8% Series A Cumulative Convertible Preferred Stock into common stock on May 6, 2025, following a reverse stock split.

Thomas Ronan Kennedy, CEO and CFO of cbdMD, Inc., reports the automatic conversion of preferred stock into common stock and open market purchases of common stock.

Director Kevin Roe converted preferred stock to common stock in cbdMD, Inc. on May 6, 2025, following a reverse stock split.

Thomas Ronan Kennedy, CEO and CFO of cbdMD, Inc., reports a transaction involving preferred stock and adjustments to common stock holdings through a trust.

Thomas Ronan Kennedy, CEO and CFO of cbdMD, Inc., reports a transaction involving preferred stock and common stock.

Director William F. Raines III acquired 75,000 shares of cbdMD, Inc. through a proxy agreement related to a settlement with CBD Industries, LLC and Majik Medicine, LLC.

Director Sybil Swift reports acquiring 4,000 shares of common stock and 2,000 stock options while disposing of 8,008 shares.

Director Stephen Scott G. reports acquisition of 4,000 common stock units and 2,000 stock options, along with the disposal of 10,138 common stock units.

Director William F. Raines III acquired 4,000 shares of common stock and 2,000 stock options in cbdMD, Inc. as part of his compensation for serving on the Board of Directors.

Director Bakari T. Sellers reports acquiring 4,000 shares of common stock and disposing of 4,000 shares, along with acquiring stock options for 2,000 shares, as compensation for board service.